FDA Issues Urgent Recall for Thyroid Medication Due to Risks

WHO:

USA Today - The U.S. Food and Drug Administration (FDA) is involved in the recall of thyroid medication.

WHAT:

WTNH - A nationwide recall of thyroid tablets has been classified as one of the FDA's most serious and urgent recalls.

WHERE:

WTNH - The recall affects thyroid medication distributed across the United States.

WHEN:

WTNH - The recall is classified as urgent, indicating immediate action is required, but no specific future date is provided in the articles.

WHY:

USA Today - The recall is due to risks associated with the thyroid medication, although specific risks are not detailed in the articles.

HOW:

WTNH - The FDA has classified the recall under its highest risk level, indicating the severity of the situation.

(UPDATED September 24, 2026 15:59 UTC)

The U.S. Food and Drug Administration is overseeing a nationwide recall of thyroid medication, which has been classified as one of the agency's most serious and urgent recalls. This recall affects thyroid tablets distributed across the United States and requires immediate action due to unspecified risks associated with the medication. The FDA has categorized this recall under its highest risk level, highlighting the severity of the situation.